Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $39.2400 (2.88%) ($38.0400 - $39.4900) on Wed. Mar. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.75% (three month average) | RSI | 65 | Latest Price | $39.2400(2.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(63%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.375% in a week (0% probabilities). VIXM(-12%) TLT(-5%) SHY(-5%) GDXJ(-5%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.375% (StdDev 4.75%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
5 Day Moving Average | $38.41(2.16%) | 10 Day Moving Average | $40.24(-2.49%) | 20 Day Moving Average | $39(0.62%) | To recent high | -11% | To recent low | 46.9% | Market Cap | $2.437b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |